Register at: http://supportahn.org/AHNClinicalEthics

The science of medicine seeks to improve and enhance the human condition, while the practice of medicine pursues health and human flourishing. The intersection of medicine, science and technology empowers us to overcome many of our mental and physical limitations in ways that could change what it means to be human.

Genetic insights and technologies help develop treatments that target causes of diseases. Technologies such as gene editing and embryo selection enable parents to curate their future children’s traits such as physical appearance, intelligence, and even immune systems. Brain-computer interfaces can help those with spinal cord injuries walk again.  Such connections can also dramatically expand human cognitive abilities.

These and other biotechnologies can improve our memories, increase our stamina and strength, alter the aging process, and eliminate many disabling conditions. These biotechnologies raise ethical questions that can touch on deeply held cultural, societal, personal, and professional values that can have far-reaching implications across the patient care continuum.

This pioneering, interdisciplinary symposium explores the practical, ethical, clinical, and societal promises and perils that fuel the human enhancement debate. AHN Clinical Ethics has assembled leading voices in the field of human enhancement to probe these matters according to the themes of 1) current innovation, 2) benefits to patient health and flourishing; and 3) policy considerations concerning access to innovation. Through enlightening talks, facilitated innovative workshops, and a candid plenary discussion.